drugset / Trial / NCT01779830
A Study of LY2624803 in Participants With Transient Insomnia
RandomizedCrossoverDouble-blind
Summary
The aim of this study is to learn how different doses of LY2624803 affect sleep in healthy people. The study has four treatment periods. Participants will receive a single dose of LY2624803, another sleeping pill, or placebo in each treatment period. The study will last approximately 1 month for each participant.
Timeline
- Start
- 2008-05
- Primary completion
- 2008-11
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY2624803 | Small molecule | 0.3 mg | Oral |
| Subject | LY2624803 | Small molecule | 3 mg | Oral |
| Subject | LY2624803 | Small molecule | 6 mg | Oral |
| Comparator | Zolpidem | Small molecule | 10 mg | Oral |